Oramed Pharmaceuticals Inc (ORMP)
2.30
-0.03
(-1.29%)
USD |
NASDAQ |
May 17, 16:00
2.305
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Free Cash Flow: -6.279M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -6.279M |
December 31, 2023 | -10.55M |
September 30, 2023 | -17.50M |
June 30, 2023 | -19.13M |
March 31, 2023 | -24.99M |
December 31, 2022 | -28.41M |
September 30, 2022 | -26.95M |
June 30, 2022 | -30.75M |
March 31, 2022 | -27.88M |
November 30, 2021 | -21.99M |
August 31, 2021 | -21.56M |
May 31, 2021 | -17.92M |
February 28, 2021 | -15.64M |
November 30, 2020 | -15.99M |
August 31, 2020 | -12.52M |
May 31, 2020 | -13.25M |
February 29, 2020 | -13.56M |
November 30, 2019 | -11.82M |
August 31, 2019 | -12.96M |
May 31, 2019 | -14.34M |
February 28, 2019 | -14.48M |
November 30, 2018 | -16.07M |
August 31, 2018 | -14.66M |
May 31, 2018 | -12.06M |
February 28, 2018 | -10.62M |
Date | Value |
---|---|
November 30, 2017 | -10.06M |
August 31, 2017 | -5.838M |
May 31, 2017 | 3.015M |
February 28, 2017 | 3.142M |
November 30, 2016 | 8.393M |
August 31, 2016 | 4.646M |
May 31, 2016 | -3.185M |
February 29, 2016 | -1.867M |
November 30, 2015 | -5.795M |
August 31, 2015 | -4.947M |
May 31, 2015 | -4.723M |
February 28, 2015 | -4.848M |
November 30, 2014 | -4.73M |
August 31, 2014 | -4.082M |
May 31, 2014 | -3.560M |
February 28, 2014 | -3.575M |
November 30, 2013 | -3.362M |
August 31, 2013 | -3.402M |
May 31, 2013 | -3.461M |
February 28, 2013 | -3.291M |
November 30, 2012 | -2.612M |
August 31, 2012 | -2.303M |
May 31, 2012 | -2.384M |
February 29, 2012 | -2.089M |
November 30, 2011 | -1.694M |
Free Cash Flow Range, Past 5 Years
-30.75M
Minimum
Jun 2022
-6.279M
Maximum
Mar 2024
-18.20M
Average
-16.74M
Median
Free Cash Flow Benchmarks
ACADIA Pharmaceuticals Inc | 63.71M |
Cassava Sciences Inc | -87.90M |
Vertex Pharmaceuticals Inc | 3.479B |
Cormedix Inc | -45.70M |
Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.476M |
Cash from Investing (Quarterly) | 30.00M |
Cash from Financing (Quarterly) | -19.00M |
Free Cash Flow Per Share (Quarterly) | -0.0356 |
Free Cash Flow Yield | -6.67% |